Tonix Pharmaceuticals Holding (TNXP) Interest & Investment Income (2015 - 2026)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Interest & Investment Income came in at $1.3 million in Q1 2026, up 241.62% year-on-year from $394000.0 in Q1 2025, and little changed quarter-over-quarter from $1.3 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Interest & Investment Income (2015 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Interest & Investment Income history runs 12 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 241.62% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 307.46% increase from a year earlier, with the FY2025 full-year figure at $4.1 million, up 18745.45% from the prior year.
- Interest & Investment Income was little changed at $1.3 million in Q1 2026 per TNXP's latest filing, from $1.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.3 million in Q1 2026 and bottomed at $1000.0 in Q4 2024.
- The 5-year median for Interest & Investment Income is $610000.0 (2022), against an average of $609384.6.
- Across the five-year window, Interest & Investment Income plunged 99.85% in 2024 and soared 134300.0% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $1.0 million in 2022, then slumped by 38.36% to $646000.0 in 2023, then plunged by 99.85% to $1000.0 in 2024, then surged by 134300.0% to $1.3 million in 2025, then increased by 0.15% to $1.3 million in 2026.
- Per Business Quant, the three latest TNXP Interest & Investment Income figures stand at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.2 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn | 1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 394,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Dec 31, 2023 | 646,000.00 |
| Sep 30, 2023 | 172,000.00 |
| Mar 31, 2023 | 897,000.00 |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 610,000.00 |
| Jun 30, 2022 | 196,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Dec 31, 2021 | -74,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 9,000.00 |
| Mar 31, 2021 | 83,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Sep 30, 2020 | 9,000.00 |
| Jun 30, 2020 | 13,000.00 |